Immunomodulation	NN
by	IN
mesenchymal	JJ
stem	NN
cells	NNS
in	IN
treating	VBG
human	JJ
autoimmune	JJ
disease-associated	JJ
lung	NN
fibrosis	NN
.	.

BACKGROUND	NN
:	:
Interstitial	JJ
pneumonia	NN
in	IN
connective	JJ
tissue	NN
diseases	NNS
(	(
CTD-IP	NN
)	)
featuring	VBG
inflammation	NN
and	CC
fibrosis	NN
is	VBZ
a	DT
leading	VBG
cause	NN
of	IN
death	NN
in	IN
CTD-IP	NN
patients	NNS
.	.

The	DT
related	JJ
autoimmune	JJ
lung	NN
injury	NN
and	CC
disturbed	JJ
self-healing	JJ
process	NN
make	VBP
conventional	JJ
anti-inflammatory	JJ
drugs	NNS
ineffective	JJ
.	.

Equipped	VBN
with	IN
unique	JJ
immunoregulatory	JJ
and	CC
regenerative	JJ
properties	NNS
,	,
mesenchymal	JJ
stem	NN
cells	NNS
(	(
MSCs	NNS
)	)
may	MD
represent	VB
a	DT
promising	JJ
therapeutic	JJ
agent	NN
in	IN
CTD-IP	NN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
aim	VBP
to	TO
define	VB
the	DT
immunopathology	NN
involved	VBN
in	IN
pulmonary	JJ
exacerbation	NN
during	IN
autoimmunity	NN
and	CC
to	TO
determine	VB
the	DT
potential	NN
of	IN
MSCs	NNS
in	IN
correcting	VBG
these	DT
disorders	NNS
.	.

METHODS	NNS
:	:
Lung	NN
and	CC
blood	NN
specimens	NNS
,	,
bronchoalveolar	JJ
lavage	NN
fluid	NN
cells	NNS
collected	VBN
from	IN
CTD-IP	NN
patients	NNS
,	,
and	CC
human	JJ
primary	JJ
lung	NN
fibroblasts	NNS
(	(
HLFs	NNS
)	)
from	IN
patients	NNS
pathologically	RB
diagnosed	VBD
with	IN
usual	JJ
interstitial	JJ
pneumonia	NN
(	(
UIP	NN
)	)
and	CC
healthy	JJ
controls	NNS
were	VBD
analyzed	VBN
by	IN
histology	NN
,	,
flow	NN
cytometry	NN
and	CC
molecular	JJ
biology	NN
.	.

T	NN
cell	NN
subsets	NNS
involved	VBN
in	IN
the	DT
process	NN
of	IN
CTD-IP	NN
were	VBD
defined	VBN
,	,
while	IN
the	DT
regulatory	JJ
functions	NNS
of	IN
MSCs	NNS
isolated	VBN
from	IN
the	DT
bone	NN
marrow	NN
of	IN
normal	JJ
individuals	NNS
(	(
HBMSCs	NNS
)	)
on	IN
cytotoxic	JJ
T	NN
cells	NNS
and	CC
CTD-UIP	NN
HLFs	NNS
were	VBD
investigated	VBN
in	FW
vitro	FW
.	.

RESULTS	NNS
:	:
Higher	JJR
frequencies	NNS
of	IN
cytotoxic	JJ
T	NN
cells	NNS
were	VBD
observed	VBN
in	IN
the	DT
lung	NN
and	CC
peripheral	JJ
blood	NN
of	IN
CTD-IP	NN
patients	NNS
,	,
accompanied	VBN
with	IN
a	DT
reduced	VBN
regulatory	JJ
T	NN
cell	NN
(	(
Treg	NNP
)	)
level	NN
.	.

CTD-UIP	NN
HLFs	NNS
secreted	VBN
proinflammatory	JJ
cytokines	NNS
in	IN
combination	NN
with	IN
upregulation	NN
of	IN
a-smooth-muscle-actin	NN
(	(
a-SMA	NN
)	)
.	.

The	DT
addition	NN
of	IN
HBMSCs	NNS
in	FW
vitro	FW
increased	VBN
Tregs	NNP
concomitant	JJ
with	IN
reduced	VBN
cytotoxic	JJ
T	NN
cells	NNS
in	IN
an	DT
experimental	JJ
cell	NN
model	NN
with	IN
dominant	JJ
cytotoxic	JJ
T	NN
cells	NNS
,	,
and	CC
promoted	VBD
Tregs	NNP
expansion	NN
in	IN
T	NN
cell	NN
subsets	NNS
from	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

HBMSCs	NNS
also	RB
significantly	RB
decreased	VBD
proinflammatory	JJ
chemokine/cytokine	NN
expression	NN
,	,
and	CC
blocked	VBD
a-SMA	NN
activation	NN
in	IN
CTD-UIP	NN
HLFs	NNS
through	IN
a	DT
TGF-b1-mediated	JJ
mechanism	NN
,	,
which	WDT
modulates	VBZ
excessive	JJ
IL-6	NN
/	:
STAT3	NN
signaling	NN
leading	VBG
to	TO
IP-10	NN
expression	NN
.	.

MSCs	NNS
secreting	VBG
a	DT
higher	JJR
level	NN
of	IN
TGF-b1	NN
appear	VBP
to	TO
have	VB
an	DT
optimal	JJ
anti-fibrotic	JJ
efficacy	NN
in	IN
BLM-induced	JJ
pulmonary	JJ
fibrosis	NN
in	IN
mice	NNS
.	.

CONCLUSIONS	NNS
:	:
Impairment	NN
of	IN
TGF-b	JJ
signal	NN
transduction	NN
relevant	JJ
to	TO
a	DT
persistent	JJ
IL-6	NN
/	:
STAT3	NN
transcriptional	JJ
activation	NN
contributes	VBZ
to	TO
reduction	NN
of	IN
Treg	NNP
differentiation	NN
in	IN
CTD-IP	NN
and	CC
to	TO
myofibroblast	NN
differentiation	NN
in	IN
CTD-UIP	NN
HLFs	NNS
.	.

HBMSCs	NNS
can	MD
sensitize	VB
TGF-b1	NN
downstream	JJ
signal	NN
transduction	NN
that	WDT
regulates	VBZ
IL-6	NN
/	:
STAT3	NN
activation	NN
,	,
thereby	RB
stimulating	VBG
Treg	NNP
expansion	NN
and	CC
facilitating	VBG
anti-fibrotic	JJ
IP-10	NN
production	NN
.	.

This	DT
may	MD
in	IN
turn	NN
block	VBP
progression	NN
of	IN
lung	NN
fibrosis	NN
in	IN
autoimmunity	NN
.	.

